Ask AI

Text Module

Share

Program Content

Activities

  • Advances and Challenges in RR B ALL
    Clinical Advances in Immune-Engager Therapies for the Treatment of Relapsed/Refractory B-ALL
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2026

    Expires: October 28, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca